Company Filing History:
Years Active: 2019
Title: Nadège Goutagny: Innovator in Hepatitis E Research
Introduction
Nadège Goutagny is a prominent inventor based in Lyons, France. She has made significant contributions to the field of virology, particularly in the study of hepatitis E virus (HEV). Her innovative work has led to the development of important methodologies for detecting antibodies related to this virus.
Latest Patents
Nadège Goutagny holds a patent for "Mutated HEV polypeptides and the use thereof for assaying anti-HEV antibodies." This patent includes polypeptides of the p-ORF2 protein of the hepatitis E virus, specifically focusing on the amino acid sequence 394-660. The invention involves mutations of three cysteines at specific positions, which enhances the ability to determine the presence of humoral responses or antibody titers against the p-ORF2 protein. This advancement is crucial for understanding infections caused by the hepatitis E virus.
Career Highlights
Throughout her career, Nadège has worked with notable companies such as bioMérieux SA and bioMérieux, Inc. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Nadège has collaborated with esteemed colleagues, including Yasemin Ataman-Onal and Soizic Daniel. These partnerships have fostered a productive environment for innovation and research in hepatitis E.
Conclusion
Nadège Goutagny's contributions to hepatitis E research through her patent and collaborations highlight her role as a key innovator in the field. Her work continues to impact the understanding and detection of this virus, paving the way for future advancements.